{"id":10186,"date":"2025-04-28T08:53:04","date_gmt":"2025-04-28T07:53:04","guid":{"rendered":"https:\/\/blog.caixaresearch.org\/?p=10186"},"modified":"2025-04-30T13:50:54","modified_gmt":"2025-04-30T12:50:54","slug":"caixaresearch-snapshot-a-caixaresearch-study-has-made-a-major-breakthrough-in-achieving-personalised-medicine-for-liver-cancer","status":"publish","type":"post","link":"https:\/\/blog.caixaresearch.org\/en\/caixaresearch-snapshot-a-caixaresearch-study-has-made-a-major-breakthrough-in-achieving-personalised-medicine-for-liver-cancer\/","title":{"rendered":"CaixaResearch Snapshot: A CaixaResearch study has made a major breakthrough in achieving personalised medicine for liver cancer"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-10260\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2025\/04\/InstantaneasCR_Abril252-300x300.jpg\" alt=\"\" width=\"300\" height=\"300\" srcset=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2025\/04\/InstantaneasCR_Abril252-300x300.jpg 300w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2025\/04\/InstantaneasCR_Abril252-1024x1024.jpg 1024w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2025\/04\/InstantaneasCR_Abril252-150x150.jpg 150w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2025\/04\/InstantaneasCR_Abril252-768x768.jpg 768w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2025\/04\/InstantaneasCR_Abril252-1536x1536.jpg 1536w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2025\/04\/InstantaneasCR_Abril252-2048x2048.jpg 2048w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p><b>More than <\/b><a href=\"https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/cancers\/11-liver-and-intrahepatic-bile-ducts-fact-sheet.pdf\" target=\"_blank\" rel=\"noopener\"><b>860 000 new cases of liver cancer <\/b><\/a><b>are diagnosed worldwide each year <\/b><span style=\"font-weight: 400;\">and hepatocellular carcinoma is the most common form, as well as one of the leading causes of cancer-related mortality. This is a particularly complex disease as it occurs in four distinct subtypes, each with its own genetic alterations and molecular characteristics.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Until now, research has come up against a considerable hurdle: <\/span><b>the lack of experimental models capable of faithfully reproducing such complexity.<\/b><span style=\"font-weight: 400;\"> This limitation significantly hinders the development of new treatments as it\u2019s not possible to predict how different patients will respond to drugs, thereby impeding progress towards more personalised therapies.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Now, a promising solution has been offered by new study, led by Dr. Josep M. Llovet, <\/span><a href=\"https:\/\/www.clinicbarcelona.org\/idibaps\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Cl\u00ednic-IDIBAPS<\/span><\/a><span style=\"font-weight: 400;\"> researcher, leader of the CaixaResearch Translational Cancer Research Programme and professor at the University of Barcelona. In collaboration with the University of Glasgow, <\/span><b>the CaixaResearch team has described 25 mouse models that reproduce, with great precision, the four known subtypes of human hepatocellular carcinoma.<\/b><span style=\"font-weight: 400;\"> By combining these models with organoids &#8211; structures that simulate miniature organs &#8211; the researchers have succeeded in creating<\/span><b> a high-performance platform capable of assessing the efficacy of different drugs according to tumour subtype.<\/b><\/p>\n<p><span style=\"font-weight: 400;\">The results, published in the prestigious journal <\/span><a href=\"https:\/\/www.nature.com\/articles\/s41586-025-08585-z\" target=\"_blank\" rel=\"noopener\"><i><span style=\"font-weight: 400;\">Nature<\/span><\/i><\/a><span style=\"font-weight: 400;\">, also detail the <\/span><b>platform&#8217;s first major achievement for drug screening: the identification of cladribine<\/b> <b>as a promising therapeutic candidate<\/b><span style=\"font-weight: 400;\">, in combination with standard-of-care therapy.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201c<\/span><i><span style=\"font-weight: 400;\">This discovery demonstrates the value of technology in identifying new therapeutic strategies and developing innovative, more precise and personalised treatments that represent an effective solution for patients<\/span><\/i><span style=\"font-weight: 400;\">\u201d explains Dr Llovet.<\/span><\/p>\n<p><b>Want to share this breakthrough?<\/b><span style=\"font-weight: 400;\"> The details of this study are also explained in <a href=\"https:\/\/x.com\/CaixaResearch\/status\/1916774513959743732\" target=\"_blank\" rel=\"noopener\">this thread on X<\/a>.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-10260\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2025\/04\/InstantaneasCR_Abril252-300x300.jpg\" alt=\"\" width=\"300\" height=\"300\" srcset=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2025\/04\/InstantaneasCR_Abril252-300x300.jpg 300w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2025\/04\/InstantaneasCR_Abril252-1024x1024.jpg 1024w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2025\/04\/InstantaneasCR_Abril252-150x150.jpg 150w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2025\/04\/InstantaneasCR_Abril252-768x768.jpg 768w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2025\/04\/InstantaneasCR_Abril252-1536x1536.jpg 1536w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2025\/04\/InstantaneasCR_Abril252-2048x2048.jpg 2048w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>More than <a href=\"https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/cancers\/11-liver-and-intrahepatic-bile-ducts-fact-sheet.pdf\" target=\"_blank\" rel=\"noopener\">860 000 new cases of liver cancer <\/a>are diagnosed worldwide each year and hepatocellular carcinoma is the most common form, as well as one of the leading causes of cancer-related mortality. This is a particularly complex disease as it occurs in four distinct subtypes, each with its own genetic alterations and molecular characteristics.<\/p>\n<p>Until now, research has come up against a considerable hurdle: the lack of experimental models capable of faithfully reproducing such complexity. This limitation significantly hinders the development of new treatments as it\u2019s not possible to predict how different patients will respond to drugs, thereby impeding progress towards more personalised therapies.<\/p>\n<p>Now, a promising solution has been offered by new study,<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[601,600],"tags":[],"class_list":["post-10186","post","type-post","status-publish","format-standard","hentry","category-research","category-science-outreach"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>CaixaResearch Snapshot: A CaixaResearch study has made a major breakthrough in achieving personalised medicine for liver cancer - Blog CaixaCi\u00e8ncia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blog.caixaresearch.org\/en\/caixaresearch-snapshot-a-caixaresearch-study-has-made-a-major-breakthrough-in-achieving-personalised-medicine-for-liver-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CaixaResearch Snapshot: A CaixaResearch study has made a major breakthrough in achieving personalised medicine for liver cancer - Blog CaixaCi\u00e8ncia\" \/>\n<meta property=\"og:description\" content=\"More than 860 000 new cases of liver cancer are diagnosed worldwide each year and hepatocellular carcinoma is the most common form, as well as one of the leading causes of cancer-related mortality. This is a particularly complex disease as it occurs in four distinct subtypes, each with its own genetic alterations and molecular characteristics. Until now, research has come up against a considerable hurdle: the lack of experimental models capable of faithfully reproducing such complexity. This limitation significantly hinders the development of new treatments as it\u2019s not possible to predict how different patients will respond to drugs, thereby impeding progress towards more personalised therapies. Now, a promising solution has been offered by new study,\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blog.caixaresearch.org\/en\/caixaresearch-snapshot-a-caixaresearch-study-has-made-a-major-breakthrough-in-achieving-personalised-medicine-for-liver-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog CaixaCi\u00e8ncia\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-28T07:53:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-30T12:50:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2025\/04\/InstantaneasCR_Abril252.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2250\" \/>\n\t<meta property=\"og:image:height\" content=\"2250\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ubikmedia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ubikmedia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/blog.caixaresearch.org\/en\/caixaresearch-snapshot-a-caixaresearch-study-has-made-a-major-breakthrough-in-achieving-personalised-medicine-for-liver-cancer\/\",\"url\":\"https:\/\/blog.caixaresearch.org\/en\/caixaresearch-snapshot-a-caixaresearch-study-has-made-a-major-breakthrough-in-achieving-personalised-medicine-for-liver-cancer\/\",\"name\":\"CaixaResearch Snapshot: A CaixaResearch study has made a major breakthrough in achieving personalised medicine for liver cancer - Blog CaixaCi\u00e8ncia\",\"isPartOf\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/en\/caixaresearch-snapshot-a-caixaresearch-study-has-made-a-major-breakthrough-in-achieving-personalised-medicine-for-liver-cancer\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/en\/caixaresearch-snapshot-a-caixaresearch-study-has-made-a-major-breakthrough-in-achieving-personalised-medicine-for-liver-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2025\/04\/InstantaneasCR_Abril252-300x300.jpg\",\"datePublished\":\"2025-04-28T07:53:04+00:00\",\"dateModified\":\"2025-04-30T12:50:54+00:00\",\"author\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/blog.caixaresearch.org\/en\/caixaresearch-snapshot-a-caixaresearch-study-has-made-a-major-breakthrough-in-achieving-personalised-medicine-for-liver-cancer\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/blog.caixaresearch.org\/en\/caixaresearch-snapshot-a-caixaresearch-study-has-made-a-major-breakthrough-in-achieving-personalised-medicine-for-liver-cancer\/#primaryimage\",\"url\":\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2025\/04\/InstantaneasCR_Abril252-300x300.jpg\",\"contentUrl\":\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2025\/04\/InstantaneasCR_Abril252-300x300.jpg\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#website\",\"url\":\"https:\/\/blog.caixaresearch.org\/\",\"name\":\"Blog CaixaCi\u00e8ncia\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/blog.caixaresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca\",\"name\":\"Ubikmedia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g\",\"caption\":\"Ubikmedia\"},\"url\":\"https:\/\/blog.caixaresearch.org\/en\/author\/ubikmedia\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CaixaResearch Snapshot: A CaixaResearch study has made a major breakthrough in achieving personalised medicine for liver cancer - Blog CaixaCi\u00e8ncia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blog.caixaresearch.org\/en\/caixaresearch-snapshot-a-caixaresearch-study-has-made-a-major-breakthrough-in-achieving-personalised-medicine-for-liver-cancer\/","og_locale":"en_US","og_type":"article","og_title":"CaixaResearch Snapshot: A CaixaResearch study has made a major breakthrough in achieving personalised medicine for liver cancer - Blog CaixaCi\u00e8ncia","og_description":"More than 860 000 new cases of liver cancer are diagnosed worldwide each year and hepatocellular carcinoma is the most common form, as well as one of the leading causes of cancer-related mortality. This is a particularly complex disease as it occurs in four distinct subtypes, each with its own genetic alterations and molecular characteristics. Until now, research has come up against a considerable hurdle: the lack of experimental models capable of faithfully reproducing such complexity. This limitation significantly hinders the development of new treatments as it\u2019s not possible to predict how different patients will respond to drugs, thereby impeding progress towards more personalised therapies. Now, a promising solution has been offered by new study,","og_url":"https:\/\/blog.caixaresearch.org\/en\/caixaresearch-snapshot-a-caixaresearch-study-has-made-a-major-breakthrough-in-achieving-personalised-medicine-for-liver-cancer\/","og_site_name":"Blog CaixaCi\u00e8ncia","article_published_time":"2025-04-28T07:53:04+00:00","article_modified_time":"2025-04-30T12:50:54+00:00","og_image":[{"width":2250,"height":2250,"url":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2025\/04\/InstantaneasCR_Abril252.jpg","type":"image\/jpeg"}],"author":"Ubikmedia","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ubikmedia","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/blog.caixaresearch.org\/en\/caixaresearch-snapshot-a-caixaresearch-study-has-made-a-major-breakthrough-in-achieving-personalised-medicine-for-liver-cancer\/","url":"https:\/\/blog.caixaresearch.org\/en\/caixaresearch-snapshot-a-caixaresearch-study-has-made-a-major-breakthrough-in-achieving-personalised-medicine-for-liver-cancer\/","name":"CaixaResearch Snapshot: A CaixaResearch study has made a major breakthrough in achieving personalised medicine for liver cancer - Blog CaixaCi\u00e8ncia","isPartOf":{"@id":"https:\/\/blog.caixaresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blog.caixaresearch.org\/en\/caixaresearch-snapshot-a-caixaresearch-study-has-made-a-major-breakthrough-in-achieving-personalised-medicine-for-liver-cancer\/#primaryimage"},"image":{"@id":"https:\/\/blog.caixaresearch.org\/en\/caixaresearch-snapshot-a-caixaresearch-study-has-made-a-major-breakthrough-in-achieving-personalised-medicine-for-liver-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2025\/04\/InstantaneasCR_Abril252-300x300.jpg","datePublished":"2025-04-28T07:53:04+00:00","dateModified":"2025-04-30T12:50:54+00:00","author":{"@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blog.caixaresearch.org\/en\/caixaresearch-snapshot-a-caixaresearch-study-has-made-a-major-breakthrough-in-achieving-personalised-medicine-for-liver-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blog.caixaresearch.org\/en\/caixaresearch-snapshot-a-caixaresearch-study-has-made-a-major-breakthrough-in-achieving-personalised-medicine-for-liver-cancer\/#primaryimage","url":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2025\/04\/InstantaneasCR_Abril252-300x300.jpg","contentUrl":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2025\/04\/InstantaneasCR_Abril252-300x300.jpg"},{"@type":"WebSite","@id":"https:\/\/blog.caixaresearch.org\/#website","url":"https:\/\/blog.caixaresearch.org\/","name":"Blog CaixaCi\u00e8ncia","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blog.caixaresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca","name":"Ubikmedia","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g","caption":"Ubikmedia"},"url":"https:\/\/blog.caixaresearch.org\/en\/author\/ubikmedia\/"}]}},"_links":{"self":[{"href":"https:\/\/blog.caixaresearch.org\/en\/wp-json\/wp\/v2\/posts\/10186","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.caixaresearch.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.caixaresearch.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/en\/wp-json\/wp\/v2\/comments?post=10186"}],"version-history":[{"count":5,"href":"https:\/\/blog.caixaresearch.org\/en\/wp-json\/wp\/v2\/posts\/10186\/revisions"}],"predecessor-version":[{"id":10263,"href":"https:\/\/blog.caixaresearch.org\/en\/wp-json\/wp\/v2\/posts\/10186\/revisions\/10263"}],"wp:attachment":[{"href":"https:\/\/blog.caixaresearch.org\/en\/wp-json\/wp\/v2\/media?parent=10186"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/en\/wp-json\/wp\/v2\/categories?post=10186"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/en\/wp-json\/wp\/v2\/tags?post=10186"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}